Table 2.
General characteristics, tumor stage and treatment.
| Characteristics | Number of patients (n, %), N=45 | |
|---|---|---|
| Year | ||
| 2010 - 2015 | 22 | (48.89%) |
| 2015 – 2020 | 23 | (51.11%) |
| Gender (female: male 1.65: 1) | ||
| Male | 17 | (37.78%) |
| Female | 28 | (62.22%) |
| Age (46 - 84; Average 66) | ||
| < 65 years | 20 | (44.44%) |
| ≥ 65 years | 25 | (55.56%) |
| Earliest Symptoms | ||
| Rapidly enlarging thyroid mass | 19 | (42.22%) |
| Hoarseness | 18 | (40.00%) |
| Dyspnea | 13 | (28.89%) |
| Dysphagia | 6 | (13.33%) |
| Choking cough after drinking water | 3 | (6.67%) |
| Tumor size (0.8 - 15 cm) | ||
| < 3cm | 5 | (11.11%) |
| 3~5cm | 14 | (31.11%) |
| 5~9cm | 22 | (48.89%) |
| ≥ 9cm | 4 | (8.89%) |
| Stage (AJCC, 2017) | ||
| IV A | 4 | (8.89%) |
| IV B | 21 | (46.67%) |
| IV C | 20 | (44.44%) |
| Metastasis | 41 | (91.11%) |
| Adjacent structures | 24 | (53.33%) |
| Muscle | 9 | (20.00%) |
| Trachea | 8 | (17.78%) |
| Esophagus | 7 | (15.56%) |
| Cervical vessels | 4 | (8.89%) |
| Cervical nerves | 2 | (4.44%) |
| Parathyroid | 2 | (4.44%) |
| Cervical lymph nodes | 23 | (51.11%) |
| Distant metastases | 19 | (42.22%) |
| Pulmonary | 16 | (35.56%) |
| Osseous | 2 | (4.44%) |
| Brain | 1 | (2.22%) |
| Liver | 1 | (2.22%) |
| Treatment | ||
| Surgery only | 24 | (53.33%) |
| Radiotherapy only | 1 | (2.22%) |
| Chemotherapy only | 2 | (4.44%) |
| Multidisciplinary synthetic therapy | 18 | (40%) |
| Surgery and radiotherapy | 4 | (8.89%) |
| Surgery and Chemotherapy | 5 | (11.11%) |
| Radiotherapy and Chemotherapy | 1 | (2.22%) |
| Surgery, Radiotherapy and Chemotherapy | 7 | (15.56%) |
| No therapy | 1 | (2.22%) |
| Surgery Method | ||
| Radical operation | 7 | (15.56%) |
| Palliative operation | 33 | (73.33%) |
| Tracheotomy | 7 | (15.56%) |
| Tracheotomy only | 1 | (2.22%) |
AJCC, American Joint Committee on Cancer.